5,315 followers
Peristomal #Pyoderma Gangrenosum Responding to Risankizumab. #TopicalTherapy https://t.co/jVujEktttc https://t.co/fgVjc30k7B
Peristomal #Pyoderma Gangrenosum Responding to Risankizumab. #TopicalTherapy https://t.co/jVujEktttc https://t.co/fgVjc30k7B